BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients

Clinical trial NCT05291286 · COMPLETED

Trial details

NCT number: NCT05291286
Sponsor: Bexion Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Neuropathy;Peripheral Chemotherapy-induced Peripheral Neuropathy

Start date: 2022-10-17
Primary completion: 2024-12-20
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.